No products in the basket.
The Stock Exchange to start trading DR “SMFG19” on 29 May
The Stock Exchange of Thailand accepts "SMFG19", a foreign securities rights instrument (Depositary Receipt or DR) that refers to shares of Sumitomo Mitsui Financial Group, Inc., Japan's largest financial institution, issued by Yuanta Securities, to begin trading on the Stock Exchange. 29 May
DR “SMFG19” denotes the stocks of Sumitomo Mitsui Financial Group, Inc., a major financial institution in Japan. The company offers a range of services including loans, securities, and credit card services across numerous countries globally. SMFG is traded on the Tokyo Stock Exchange in Japan.
DR “SMFG19” will begin trading on the stock exchange. From May 29, 2024 onwards,
Depositary Receipts (DR) are financial instruments that represent ownership of shares in a foreign company. They allow investors to indirectly invest in foreign securities while trading in their local currency, in this case, baht. DR “SMFG19” refers to a specific Depositary Receipt, which can be further explored for detailed information.
For comprehensive details on DR “SMFG19,” interested individuals can refer to the Securities and Exchange Commission (SEC) website at www.sec.or.th. Additionally, they can visit the website of Yuanta Securities (Thailand) Company Limited at https://dr.yuanta.co.th for specific information related to this particular DR.
For a broader understanding of DR products and investment opportunities, additional information is available at www.setinvestnow.com/th/dr. This resource can provide insights into various DR offerings and their potential benefits for investors.
Discover more from Thailand Business News
Subscribe to get the latest posts sent to your email.
